propranolol (Q423364)

propranolol (English)

19 November 2016

canonical SMILES

CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O

1 reference

World Health Organisation international non-proprietary name

propranolol (English)

19 November 2016

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

propranolol (English)

1 reference

Antiangiogenic Activity and Chemical Derivatization of the Neurotoxic Acetogenin Annonacin Isolated from Asimina triloba

propranolol (English)

3 October 2016

1 reference

1 reference

0 references

0 references

0 references

0 references

medical condition treated

myocardial infarction

1 reference

13 December 2016

arterial hypertension

2 references

13 December 2016

2 October 2018

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

congestive heart failure

1 reference

13 December 2016

1 reference

13 December 2016

ventricular fibrillation

1 reference

supraventricular tachycardia

13 December 2016

1 reference

13 December 2016

1 reference

2 October 2018

anxiety

1 reference

2 October 2018

migraine

1 reference

2 October 2018

thyroid crisis

1 reference

significant drug interaction

Basic and Clinical Pharmacology 14th Edition (English)

ISBN-13

9781259641152

capillary hemangioma

0 references

bromperidol

1 reference

https://www.drugbank.ca/drugs/DB00571

floctafenine

1 reference

https://www.drugbank.ca/drugs/DB00571

adrenergic beta-agonists

1 reference

https://www.drugbank.ca/drugs/DB00571

methacholine

1 reference

https://www.drugs.com/drug-interactions/propranolol-index.html

rivastigmine

1 reference

https://www.drugs.com/drug-interactions/propranolol-index.html

verapamil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

digoxin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

crizotinib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

verapamil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

haloperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

diltiazem

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clonidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rivastigmine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(−)-selegiline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ergotamine

vasoconstriction

1 reference

A reference set of clinically relevant adverse drug-drug interactions

methyldopa

1 reference

A reference set of clinically relevant adverse drug-drug interactions

diltiazem

1 reference

A reference set of clinically relevant adverse drug-drug interactions

terazosin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prazosin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

doxazosin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clonidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxonidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lercanidipine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(E/Z)-doxepin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluphenazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(−)-selegiline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tamsulosin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfuzosin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

diltiazem

myocardial depression

1 reference

A reference set of clinically relevant adverse drug-drug interactions

mefloquine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ergotamine

peripheral ischemia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sinoatrial arrest

1 reference

A reference set of clinically relevant adverse drug-drug interactions

atrioventricular block

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

digoxin

toxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxonidine

withdrawal hypertension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dronedarone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

decreased heart rate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

shortened atrioventricular conduction time

1 reference

A reference set of clinically relevant adverse drug-drug interactions

atrioventricular block

1 reference

A reference set of clinically relevant adverse drug-drug interactions

disopyramide

short coagulation time

1 reference

A reference set of clinically relevant adverse drug-drug interactions

disopyramide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-propafenone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-propafenone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

mefloquine

abnormal electrocardiogram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

mefloquine

pulseless electrical activity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(E/Z)-doxepin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(−)-selegiline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

haloperidol

pulseless electrical activity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

seizure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

infective psychosis

1 reference

A reference set of clinically relevant adverse drug-drug interactions

extrapyramidal symptoms

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

1 reference

Adrenergic receptor, beta 3

17 August 2016

subject has role

antagonist

1 reference

17 August 2016

1 reference

intravenous administration

17 August 2016

route of administration

oral administration

0 references

0 references

legal status (medicine)

boxed warning

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

Australian pregnancy category C

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category E

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Propranolol

last update

15 January 2017

mass

259.157229 dalton

1 reference

propranolol (English)

3 October 2016

1 reference

2 references

5 March 2018

15 March 2018

1 reference

MeSH descriptor ID

D011433

15 March 2018

antihypertensive drug

1 reference

15 March 2018

1 reference

National Library of Israel J9U ID

15 March 2018

0 references

0 references

0 references

0 references

Propranolol

0 references

Identifiers

0 references

0 references

InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3

1 reference

propranolol (English)

19 November 2016

2 references

propranolol (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

525-66-6

2 references

propranolol (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=525-66-6

8 April 2021

1 reference

propranolol (English)

19 November 2016

2 references

propranolol (English)

19 November 2016

Reaxys registry number

987417

1 reference

propranolol (English)

3 October 2016

ChEBI ID

8499

mapping relation type

2 references

PROPRANOLOL (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3

1 reference

PROPRANOLOL (English)

19 November 2016

2 references

inferred from InChIKey

12264958

2 references

based on heuristic

inferred from InChIKey

MSBNK-Athens_Univ-AU110801

1 reference

MassBank accession ID

SM855601

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

MSBNK-Keio_Univ-KO003927

0 references

MSBNK-Keio_Univ-KO003928

0 references

MSBNK-Keio_Univ-KO003929

0 references

MSBNK-Keio_Univ-KO003930

0 references

MSBNK-Keio_Univ-KO003931

0 references

MSBNK-Keio_Univ-KO009171

0 references

MSBNK-Keio_Univ-KO009172

0 references

MSBNK-Keio_Univ-KO009173

0 references

MSBNK-Keio_Univ-KO009174

0 references

MSBNK-Keio_Univ-KO009175

0 references

MSBNK-UFZ-UA006101

0 references

MSBNK-Waters-WA001110

0 references

MSBNK-Waters-WA001111

0 references

MSBNK-Waters-WA001112

0 references

MSBNK-Waters-WA001113

0 references

MSBNK-Waters-WA001114

0 references

SPLASH

splash10-0159-0910000000-d7db5bab374a7cf02fd3

0 references

splash10-03di-0090000000-057a63162f5e674c4ce6

0 references

splash10-03di-0190000000-87c354c205b94f5f06e1

0 references

splash10-0cl0-4930000000-1eecec66280a12a94b9d

0 references

splash10-0ab9-4900000000-ddd58df17ce1f65a7559

0 references

splash10-0a4i-4900000000-711c94a7c2e5c24e9e84

0 references

splash10-0a6r-3900000000-54967b29c739db5eb0d5

0 references

splash10-03di-0190000000-f4e36c8dd4e96992c94d

0 references

splash10-0830-4920000000-835447ce35e37ab07193

0 references

splash10-0ab9-5900000000-25248a6b39724a02096d

0 references

splash10-0a4i-4900000000-5663a764e73595039671

0 references

splash10-0a6r-3900000000-20d14f48fc5615796a2d

0 references

splash10-00lr-0910000000-d51a9e2266c2de91bfaa

0 references

splash10-03di-0090000000-d6c29037a12e6224fc5c

0 references

splash10-03di-3590000000-e89d2a443f5d3480df83

0 references

splash10-0avi-7900000000-073897b09869caa5bcdc

0 references

splash10-0ab9-7900000000-566e620bc2a178d2a8e7

0 references

splash10-0ab9-6900000000-21115e5f6c969e2f9e0f

0 references

splash10-0adi-5900000000-c8d935c939307db2ee51

0 references

splash10-03di-0090000000-ee9d9c871e322202a948

0 references

splash10-03di-0290000000-53507ada5020c820cd0f

0 references

splash10-0avi-5900000000-95293e6a5f843d0cc282

0 references

splash10-0ab9-9700000000-264398d3bc59c8ced5ed

0 references

splash10-0adi-9700000000-f5825268222d45a4ce95

0 references

splash10-0159-1900000000-63f0b6b57a76617acc2d

0 references

splash10-00di-9500000000-122203085c028de6cbe4

0 references

splash10-0aor-0900000000-8c16e93fb43526b3c84f

0 references

splash10-004i-0900000000-228cc85de86e4b27504a

0 references

splash10-00di-9200000000-2f102916e2fe0f6c1f4b

0 references

splash10-060r-4900000000-c1976ec4cf413372eb24

0 references

splash10-05i0-4900000000-dfc2a11c8d505e07028b

0 references

splash10-0159-0900000000-ece05c33751eecfe1c79

0 references

splash10-00lr-0900000000-cbbd556232c991733f57

0 references

splash10-03di-4590000000-aaddd1419df983db1236

0 references

splash10-0fk9-2932000000-fa245a17a643ef33a0b2

0 references

splash10-05fr-9000000000-84923a2dc3053801527a

0 references

splash10-03di-0090000000-f8c39664b694f5784865

0 references

DSSTox substance ID

DTXSID6023525

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

1 reference

propranolol (English)

ECHA Substance Infocard ID

19 November 2016

100.007.618

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.007.618

27 December 2018

Propranolol (English)

quotation

CAS no.: 525-66-6 (English)

1 reference

Propranolol (English)

publication date

17 November 2015

1 reference

D02.455.426.559.847.638.945

propranolol (English)

19 November 2016

Propranolol

0 references

MeSH tree code

D02.033.100.624.698.711

broader concept

phenoxypropanolamines

0 references

D02.033.755.624.698.711

broader concept

phenoxypropanolamines

0 references

D02.092.063.624.698.711

broader concept

phenoxypropanolamines

0 references

0 references

0 references

1 reference

propranolol (English)

19 November 2016

DrugBank ID

DB00571

1 reference

Human Metabolome Database ID

HMDB0001849

2 references

based on heuristic

inferred from InChIKey

2 references

propranolol (English)

19 November 2016

MedlinePlus drug identifier

a682607

route of administration

oral administration

medical condition treated

cardiovascular disease

0 references

a615024

route of administration

oral administration

medical condition treated

infantile hemangioma

0 references

PatientsLikeMe treatment ID

0 references

1 reference

propranolol (English)

19 November 2016

0 references

1 reference

1 reference

propranolol (English)

3 October 2016

1 reference

electronic Essential Medicines List medicine ID

propranolol (English)

3 October 2016

propranolòlo

0 references

392

0 references

Encyclopædia Britannica Online ID

science/propranolol

subject named as

propranolol

0 references

1 reference

28 October 2013

1 reference

9 July 2020

Microsoft Academic ID (discontinued)

0 references

0 references

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

UK Parliament thesaurus ID

439271

subject named as

Propranolol

0 references

UMLS CUI

C0033497

1 reference

propranolol (English)